Biblio print

Tree Display

AceDB Schema

XML Display


Author Report for: Jennings A

No contact information in database for Jennings A

    Title: Trelagliptin (SYR-472, Zafatek), Novel Once-Weekly Treatment for Type 2 Diabetes, Inhibits Dipeptidyl Peptidase-4 (DPP-4) via a Non-Covalent Mechanism
    Grimshaw CE, Jennings A, Kamran R, Ueno H, Nishigaki N, Kosaka T, Tani A, Sano H, Kinugawa Y and Takeuchi K <2 more author(s)>
    Ref: PLoS ONE, 11:e0157509, 2016 : PubMed


    Title: Design and synthesis of pyrimidinone and pyrimidinedione inhibitors of dipeptidyl peptidase IV
    Zhang Z, Wallace MB, Feng J, Stafford JA, Skene RJ, Shi L, Lee B, Aertgeerts K, Jennings A and Gwaltney SL <5 more author(s)>
    Ref: Journal of Medicinal Chemistry, 54:510, 2011 : PubMed


    Title: Structural and kinetic analysis of the substrate specificity of human fibroblast activation protein alpha
    Aertgeerts K, Levin I, Shi L, Snell GP, Jennings A, Prasad GS, Zhang Y, Kraus ML, Salakian S and Tennant MG <2 more author(s)>
    Ref: Journal of Biological Chemistry, 280:19441, 2005 : PubMed


Send your questions or comments to :
Mail to: Nicolas Lenfant, Thierry Hotelier, Yves Bourne, Pascale Marchot and Arnaud Chatonnet.
Please cite: Lenfant 2013 Nucleic.Acids.Res. or Marchot Chatonnet 2012 Prot.Pept Lett.
For technical information about these pages see:
ESTHER Home Page and ACEDB Home Page
AcePerl Lincoln Stein Home Page

Acknowledgements and disclaimer